GANX Straddle Strategy
GANX (Gain Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Gain Therapeutics, Inc. is a biotechnology firm specializing in the creation of advanced treatments for conditions originating from improperly folded proteins. The company primarily directs its efforts towards rare genetic disorders and neurological ailments. It employs its unique Site-Directed Enzyme Enhancement Therapy (SEE-Tx) platform to pinpoint specific allosteric sites on malformed proteins. Subsequently, Gain Therapeutics identifies proprietary small molecules designed to bind to these locations, thereby restoring correct protein conformation and alleviating the disease. Their current development pipeline includes several structurally targeted allosteric regulator candidates aimed at combating a range of diseases, such as Morquio B, GM1 gangliosidosis (GM1), neuronopathic Gaucher disease, GBA1 Parkinson's, Krabbe, and Mucopolysaccharidosis type 1. Established in 2017, the company is headquartered in Bethesda, Maryland.
GANX (Gain Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $90.4M, a beta of 0.20 versus the broader market, a 52-week range of 1.53-4.34, average daily share volume of 776K, a public-listing history dating back to 2021, approximately 21 full-time employees. These structural characteristics shape how GANX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.20 indicates GANX has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a straddle on GANX?
A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.
GANX snapshot
As of August 14, 2026, spot at $2.15, ATM IV 138.00%, IV rank 29.12%, expected move 39.56%. The straddle on GANX below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this straddle structure on GANX specifically: GANX IV at 138.00% is on the cheap side of its 1-year range, which favors premium-buying structures like a GANX straddle, with a market-implied 1-standard-deviation move of approximately 39.56% (roughly $0.85 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated GANX expiries trade a higher absolute premium for lower per-day decay. Position sizing on GANX should anchor to the underlying notional of $2.15 per share and to the trader's directional view on GANX stock.
GANX straddle setup
The GANX straddle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With GANX at $2.15 on that close, the first option leg uses a $2.15 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed GANX chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 GANX shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $2.15 | N/A |
| Buy 1 | Put | $2.15 | N/A |
GANX straddle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.
GANX straddle payoff curve
Modeled P&L at expiration across a range of underlying prices for the straddle on GANX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use straddle on GANX
Straddles on GANX are pure-volatility plays that profit from large moves in either direction; traders typically buy GANX straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
GANX thesis for this straddle
The market-implied 1-standard-deviation range for GANX extends from approximately $1.30 on the downside to $3.00 on the upside. A GANX long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. Current GANX IV rank near 29.12% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on GANX at 138.00%. As a Healthcare name, GANX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to GANX-specific events.
GANX straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. GANX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move GANX alongside the broader basket even when GANX-specific fundamentals are unchanged. Always rebuild the position from current GANX chain quotes before placing a trade.
Frequently asked questions
- What is a straddle on GANX?
- A straddle on GANX is the straddle strategy applied to GANX (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With GANX stock at $2.15 on the most recent close, the strikes shown on this page are snapped to the nearest listed GANX chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are GANX straddle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the GANX straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 138.00%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a GANX straddle?
- The breakeven for the GANX straddle priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The GANX market-implied 1-standard-deviation expected move in the same options snapshot is approximately 39.56%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a straddle on GANX?
- Straddles on GANX are pure-volatility plays that profit from large moves in either direction; traders typically buy GANX straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
- How does current GANX implied volatility affect this straddle?
- GANX ATM IV is at 138.00% with IV rank near 29.12%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.